Cyclodextrin cladribine formulations
US6194395A · kind A · utility
15Cited by
5References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 1999 |
| Grant date | Feb 27, 2001 |
| Priority date | — |
| Expiry date | Feb 25, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2077
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided by the present invention liquid injectable and oral solid pharmaceutical dosage forms containing a mixture of cladribine (2-chloro-2'-deoxyadenosine; 2-CdA) and cyclodextrin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.